文献速递毛发、甲与色素性疾病银屑病与炎症性皮肤病

斑秃存在全身性17型与2型细胞因子失调,或参与疾病相关心理困扰

Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity.
PubMed 文献 · Br J Dermatol · 2019-07-17

该研究对斑秃患者、银屑病关节炎患者及健康对照者的血浆细胞因子进行多重分析,并用HADS量表评估抑郁焦虑。结果显示斑秃患者IL-17A、IL-17F、IL-21、IL-23及IL-33、IL-31、IL-17E升高,18%出现抑郁症状、51%出现焦虑症状,IL-22和IL-17E水平与抑郁正相关。

要点

  • 斑秃患者存在17型与2型细胞因子升高的全身炎症特征
  • 斑秃患者抑郁症状占18%、焦虑症状占51%
  • IL-22和IL-17E水平正向预测抑郁评分

核心结论

  • 斑秃患者血浆17型和2型细胞因子升高,提示全身细胞因子谱可能同时参与斑秃发病及伴发的抑郁。

研究设计与样本

  • 研究对斑秃患者、银屑病关节炎患者及健康对照者的血浆细胞因子进行多重分析,并用医院焦虑抑郁量表(HADS)评估抑郁和焦虑。

主要发现

  • 斑秃患者IL-17A、IL-17F、IL-21、IL-23升高,提示17型免疫反应。
  • 斑秃患者2型细胞因子IL-33、IL-31和IL-17E(IL-25)循环水平也显著升高。
  • 与银屑病关节炎相比,斑秃的IL-17F、IL-17E和IL-23水平更高。
  • HADS评分显示18%的斑秃患者出现抑郁症状,51%出现焦虑症状。
  • 线性回归模型显示IL-22和IL-17E水平与抑郁呈正向显著关联。

关键数值与推荐

  • 斑秃患者18%出现抑郁症状、51%出现焦虑症状(HADS评分)。
  • IL-22和IL-17E水平与抑郁评分呈正向显著关联(线性回归模型)。

临床怎么用

  • 斑秃治疗策略或需兼顾17型与2型免疫失调,而非仅针对CD8+ T细胞反应。
  • 对斑秃患者应关注抑郁和焦虑共病,并可结合细胞因子水平评估心理困扰风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alopecia areata (AA) is a common autoimmune disease, causing patchy hair loss that can progress to involve the entire scalp (totalis) or body (universalis). CD8+ NKG2D+ T cells dominate hair follicle pathogenesis, but the specific mechanisms driving hair loss are not fully understood. OBJECTIVES: To provide a detailed insight into the systemic cytokine signature associated with AA, and to assess the association between cytokines and depression. METHODS: We conducted multiplex analysis of plasma cytokines from patients with AA, patients with psoriatic arthritis (PsA) and healthy controls. We used the Hospital Anxiety and Depression Scale (HADS) to assess the occurrence of depression and anxiety in our cohort. RESULTS: Our analysis identified a systemic inflammatory signature associated with AA, characterized by elevated levels of interleukin (IL)-17A, IL-17F, IL-21 and IL-23 indicative of a type 17 immune response. Circulating levels of the type 2 cytokines IL-33, IL-31 and IL-17E (IL-25) were also significantly increased in AA. In comparison with PsA, AA was associated with higher levels of IL-17F, IL-17E and IL-23. We hypothesized that circulating inflammatory cytokines may contribute to wider comorbidities associated with AA. Our assessment of psychiatric comorbidity in AA using HADS scores showed that 18% and 51% of people with AA experienced symptoms of depression and anxiety, respectively. Using linear regression modelling, we identified that levels of IL-22 and IL-17E are positively and significantly associated with depression. CONCLUSIONS: Our data highlight changes in both type 17 and type 2 cytokines among people with AA, suggesting that complex systemic cytokine profiles may contribute both to the pathogenesis of AA and to the associated depression. What's already known about this topic? NKG2D+ CD8+ T cells cause hair loss in alopecia areata (AA) but the immunological mechanisms underlying the disease are not fully understood. AA is associated with changes in levels of interleukin (IL)-6, tumour necrosis factor-α, IL-1β and type 17 cytokines. Psychiatric comorbidity is common among people with AA. What does this study add? People with AA have increased plasma levels of the type 2 cytokines IL-33, IL-31 and IL-17E (IL-25), in addition to the type 17 cytokines IL-17A, IL-21, IL-23 and IL-17F. Levels of IL-17E and IL-22 positively predict depression score. What is the translational message? AA is associated with increased levels of multiple inflammatory cytokines, implicating both type 17- and type 2 immune pathways. Our data indicate that therapeutic strategies for treating AA may need to address the underlying type 17- and type 2 immune dysregulation, rather than focusing narrowly on the CD8+ T-cell response. An immunological mechanism might contribute directly to the depression observed in people with AA.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Bain KA, McDonald E, Moffat F, et al. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity. Br J Dermatol. 2019. PMID: 30980732. doi:10.1111/bjd.18008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。